Results
|
|
2361.
|
|
|
|
2362.
|
Lack of inhibition of CYP2C8 by saroglitazar magnesium: In vivo assessment using montelukast, rosiglitazone, pioglitazone, repaglinide and paclitaxel as victim drugs in Wistar rats. [electronic resource] by
- Giri, Poonam
- Delvadia, Prashant
- Ladani, Meera K
- Prajapati, Namrata
- Gupta, Lakshmikant
- Patel, Nirmal
- Joshi, Vipul
- Giri, Shyamkumar
- Jain, Mukul R
- Srinivas, Nuggehally R
- Patel, Pankaj R
Producer: 20190617
In:
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences vol. 130
Availability: No items available.
|
|
|
2363.
|
|
|
|
2364.
|
|
|
|
2365.
|
|
|
|
2366.
|
|
|
|
2367.
|
|
|
|
2368.
|
|
|
|
2369.
|
|
|
|
2370.
|
|
|
|
2371.
|
Distinct association of serum FGF21 or adiponectin levels with clinical parameters in patients with type 2 diabetes. [electronic resource] by
- Eto, Kazuhiro
- Tumenbayar, Bayasgalan
- Nagashima, Shu-ichi
- Tazoe, Fumiko
- Miyamoto, Michiaki
- Takahashi, Manabu
- Ando, Akihiko
- Okada, Kenta
- Yagyu, Hiroaki
- Ishibashi, Shun
Producer: 20100929
In:
Diabetes research and clinical practice vol. 89
Availability: No items available.
|
|
|
2372.
|
|
|
|
2373.
|
|
|
|
2374.
|
|
|
|
2375.
|
|
|
|
2376.
|
|
|
|
2377.
|
|
|
|
2378.
|
A randomized-controlled trial to investigate the effects of rivoglitazone, a novel PPAR gamma agonist on glucose-lipid control in type 2 diabetes. [electronic resource] by
- Kong, A P S
- Yamasaki, A
- Ozaki, R
- Saito, H
- Asami, T
- Ohwada, S
- Ko, G T C
- Wong, C K
- Leung, G T C
- Lee, K F
- Yeung, C Y
- Chan, J C N
Producer: 20111007
In:
Diabetes, obesity & metabolism vol. 13
Availability: No items available.
|
|
|
2379.
|
|
|
|
2380.
|
|